Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matcheri S Keshavan, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Matcheri Keshavan and Raquelle Mesholam-Gately.
Matcheri Keshavan
Connection Strength
3.792
Raquelle Mesholam-Gately
  1. What is my diagnosis, Doc?: Discussing psychosis diagnosis with patients and families. Schizophr Res. 2022 01; 239:92-94.
    View in: PubMed
    Score: 0.973
  2. Are we ready for a name change for schizophrenia? A survey of multiple stakeholders. Schizophr Res. 2021 12; 238:152-160.
    View in: PubMed
    Score: 0.965
  3. Altered working memory-related brain activity in children at familial high risk for psychosis: A preliminary study. Schizophr Res. 2022 02; 240:186-192.
    View in: PubMed
    Score: 0.245
  4. Functional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophrenia. Psychol Med. 2020 Nov 13; 1-10.
    View in: PubMed
    Score: 0.226
  5. Association of white matter microstructure and extracellular free-water with cognitive performance in the early course of schizophrenia. Psychiatry Res Neuroimaging. 2020 11 30; 305:111159.
    View in: PubMed
    Score: 0.222
  6. Social cognition in early course of schizophrenia: Exploratory factor analysis. Psychiatry Res. 2019 02; 272:737-743.
    View in: PubMed
    Score: 0.199
  7. Reduced subicular subdivisions of the hippocampal formation and verbal declarative memory impairments in young relatives at risk for schizophrenia. Schizophr Res. 2013 Dec; 151(1-3):154-7.
    View in: PubMed
    Score: 0.139
  8. Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy. Psychiatry Res. 2013 Aug 30; 209(1):21-6.
    View in: PubMed
    Score: 0.134
  9. Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia. Mol Psychiatry. 2022 Feb 10.
    View in: PubMed
    Score: 0.062
  10. Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial. Psychiatr Serv. 2021 Sep 02; appips202000552.
    View in: PubMed
    Score: 0.060
  11. Hyperactivation of Posterior Default Mode Network During Self-Referential Processing in Children at Familial High-Risk for Psychosis. Front Psychiatry. 2021; 12:613142.
    View in: PubMed
    Score: 0.057
  12. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study. Mol Psychiatry. 2021 09; 26(9):5357-5370.
    View in: PubMed
    Score: 0.057
  13. Cerebellar-Cortical Connectivity Is Linked to Social Cognition Trans-Diagnostically. Front Psychiatry. 2020; 11:573002.
    View in: PubMed
    Score: 0.056
  14. Altered resting-state functional connectivity in young children at familial high risk for psychotic illness: A preliminary study. Schizophr Res. 2020 02; 216:496-503.
    View in: PubMed
    Score: 0.053
  15. Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum. Psychol Med. 2020 07; 50(10):1623-1632.
    View in: PubMed
    Score: 0.052
  16. Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT). Psychiatry Res. 2019 08; 278:116-124.
    View in: PubMed
    Score: 0.051
  17. A comparison of neurocognition and functioning in first episode psychosis populations: do research samples reflect the real world? Soc Psychiatry Psychiatr Epidemiol. 2019 Mar; 54(3):291-301.
    View in: PubMed
    Score: 0.049
  18. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophr Res. 2018 05; 195:306-317.
    View in: PubMed
    Score: 0.046
  19. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis. Schizophr Res. 2016 May; 173(1-2):1-12.
    View in: PubMed
    Score: 0.041
  20. Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study. BMC Psychiatry. 2014 Dec 04; 14:335.
    View in: PubMed
    Score: 0.037
  21. Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth. Schizophr Res. 2014 Sep; 158(1-3):45-51.
    View in: PubMed
    Score: 0.036
  22. Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res. 2012 Oct; 141(1):65-71.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.